Axa S.A. Agenus Inc Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $20,806 - $33,475	-10,300 Closed	0 $0
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $20,188 - $32,342	10,300 New	10,300 $21,000
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $574,340 - $848,068	-244,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $640,648 - $1.26 Million	219,400 Added 877.6%	244,400 $787,000
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $124,500 - $165,750	25,000 New	25,000 $131,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.